It focuses on distribution, retail, research and development and production of health-related products, such as preventive treatment and diagnostic care. It has more than 65,438+0,500 subsidiaries, and six listed companies, including Sinopharm Holdings, Sinopharm Shares, Sinopharm Consistent, Tiantan Bio, Hyundai Pharmaceutical and China Traditional Chinese Medicine.
China Pharmaceutical Group Co., Ltd. is making every effort to promote the all-round development of the group's five platforms-modern logistics and distribution integrated operation platform, Industry-University-Research integrated scientific and technological innovation platform, national drug retail chain network, national narcotic drug distribution network, national biological product marketing and cold chain distribution network, national medical device consumables product distribution network, scientific instruments and medical devices, medical research and engineering design, international operation of medicine and overseas industries, medical exhibitions and media, medical and health industries, and form an innovative type with the core competitiveness of medical and health industries.